{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:32:20Z","timestamp":1787772740120,"version":"build-2784847793"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Currently, various destructive and ablative treatment options are conventionally used for warts, but all of them are limited in some form by their adverse effects, high recurrences, suboptimal effectiveness, and the need to treat every wart. Lately, immunotherapy has emerged as a safe treatment relying on biological substances that modulate the immune system to achieve disease control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>We aimed at conducting a placebo-controlled study to compare the rate of efficacy of intralesional MMR vaccine with vitamin D3 in the management of recalcitrant extragenital warts in immune-competent adults. Follow-up was done at third and sixth month.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Patients were divided into three groups, namely, group A, B, and C. Groups A, B, and C received intralesional MMR vaccine, vitamin D3 and normal saline, respectively, in the largest wart. The injections were repeated every 2 weeks, for a maximum of four injections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among injected warts, in group A, complete clearance was seen in 29 (87.8%) patients, partial clearance in two (6.1%) and no response in two (6.1%) patients. In group B, 24 (77.4%) patients, five (16.1%) patients, and two (6.5%) patients showed signs of complete, partial, and no clearance, respectively, in injected warts. Complete response in distant warts was seen in 25 (75.7%) patients in group A and 20 (64.5%) patients in group B. There was no statistically significant difference between responses of the two groups. In group C, only three (12.5%) patients had complete clearance in injected warts, and none in distant warts. Recurrence was seen in two (6.4%) patients, each in group B and C. However, for management of verruca plana MMR was found to be superior to vitamin D3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>Our study was limited by a small sample size, absence of immunological analysis, and limited follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>MMR vaccine and vitamin D3 are equally effective and safe treatment option for multiple, recalcitrant warts, as well as warts on difficult to treat sites with minimal recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/idoj.idoj_573_20","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T11:01:13Z","timestamp":1637492473000},"page":"879-887","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of the Efficacy of Intralesional Measles, Mumps, and Rubella Vaccine with Intralesional Vitamin D3 as Immunotherapies in the Treatment of Recalcitrant Cutaneous Warts in Adult- A Randomized Placebo-Controlled Study"],"prefix":"10.4103","volume":"12","author":[{"given":"Alpana","family":"Mohta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh K.","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20240828","first-page":"2","article-title":"Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine","volume":"1","author":"Braaten","year":"2008","journal-title":"Rev Obstet Gynecol"},{"key":"R2-14-20240828","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1370\/afm.1508","article-title":"Natural course of cutaneous warts among primary schoolchildren: A prospective cohort study","volume":"11","author":"Bruggink","year":"2013","journal-title":"Ann Fam Med"},{"key":"R3-14-20240828","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1525-1470.2003.20318.x","article-title":"Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens","volume":"20","author":"Clifton","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"R4-14-20240828","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3121\/cmr.4.4.273","article-title":"An armamentarium of wart treatments","volume":"4","author":"Lipke","year":"2006","journal-title":"Clin Med Res"},{"key":"R5-14-20240828","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1468-3083.2008.02719.x","article-title":"Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: An open label pilot study","volume":"22","author":"Gupta","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-14-20240828","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CDLI.8.2.209-220.2001","article-title":"Cell-mediated immune response to human papillomavirus infection","volume":"8","author":"Scott","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"R7-14-20240828","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1468-3083.2010.03611.x","article-title":"Intralesional immunotherapy of common warts: Successful treatment with mumps, measles and rubella vaccine","volume":"24","author":"Nofal","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R8-14-20240828","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1525-1470.2008.00630.x","article-title":"One-year experience with candida antigen immunotherapy for warts and molluscum","volume":"25","author":"Maronn","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"R9-14-20240828","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/0378-6323.79694","article-title":"Intralesional immunotherapy for the management of warts","volume":"77","author":"Chandrashekar","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R10-14-20240828","first-page":"368623","article-title":"Successful treatment of refractory wart with a topical activated vitamin D in a renal transplant recipient","volume":"2011","author":"Moscarelli","year":"2011","journal-title":"Case Rep Transplant"},{"key":"R11-14-20240828","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"R12-14-20240828","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/pde.14280","article-title":"A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children","volume":"37","author":"Mohta","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"R13-14-20240828","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/jocd.13272","article-title":"Comparative clinical study of the efficacy of intralesional MMR vaccine vs intralesional vitamin D injection in treatment of warts","volume":"19","author":"Shaldoum","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"R14-14-20240828","doi-asserted-by":"crossref","first-page":"e12997","DOI":"10.1111\/dth.12997","article-title":"Intralesional vitamin D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: A comparative case\u2013control study?","volume":"32","author":"Fathy","year":"2019","journal-title":"Dermatol Ther"},{"key":"R15-14-20240828","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/0974-2077.150740","article-title":"Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine","volume":"7","author":"Garg","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"key":"R16-14-20240828","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/2229-5178.190487","article-title":"Evolving role of immunotherapy in the treatment of refractory warts","volume":"7","author":"Thappa","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"R17-14-20240828","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/idoj.IDOJ_111_18","article-title":"A randomized double blind controlled study comparing the efficacy of intralesional MMR vaccine with normal saline in the treatment of cutaneous warts","volume":"9","author":"Agrawal","year":"2018","journal-title":"Indian Dermatol Online J"},{"key":"R18-14-20240828","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7241\/ourd.20134.118","article-title":"Evaluation of the efficacy of a combination-measles, mumps and rubella vaccine in the treatment of plantar warts","volume":"4","author":"Mohamad","year":"2013","journal-title":"Our Dermatol Online"},{"key":"R19-14-20240828","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/2277-9175.129701","article-title":"Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart","volume":"3","author":"Zamanian","year":"2014","journal-title":"Adv Biomed Res"},{"key":"R20-14-20240828","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4103\/ijpd.IJPD_106_18","article-title":"Evaluation of efficacy and safety of intralesional Measles-Mumps-Rubella virus vaccine for the treatment of common warts in children and adolescents","volume":"20","author":"Mahajan","year":"2019","journal-title":"Indian J Paediatr Dermatol"},{"key":"R21-14-20240828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/idoj.IDOJ_142_18","article-title":"The efficacy and safety of intralesional immunotherapy with measles, mumps, rubella virus vaccine for the treatment of common warts in adults","volume":"10","author":"Chauhan","year":"2019","journal-title":"Indian Dermatol Online J"},{"key":"R22-14-20240828","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1203475415602841","article-title":"Intralesional Vitamin D injection may be effective treatment option for warts","volume":"20","author":"Akta\u015f","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"R23-14-20240828","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/JCAS.JCAS_82_16","article-title":"Safety and efficacy of intralesional vitamin D3 in cutaneous warts: An open uncontrolled trial","volume":"10","author":"Kavya","year":"2017","journal-title":"J Cutan Aesthet Surg"},{"key":"R24-14-20240828","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1203475417704180","article-title":"Intralesional Vitamin D3 injection in treatment of recalcitrant warts: A novel proposition","volume":"21","author":"Raghukumar","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"R25-14-20240828","doi-asserted-by":"crossref","first-page":"197","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20180953","article-title":"A comparative study between intralesional PPD and vitamin D3 in treatment of viral warts","volume":"4","author":"Singh","year":"2018","journal-title":"Int J Res Dermatol"},{"key":"R26-14-20240828","first-page":"e13034","article-title":"Intralesional vitamin D3 versus intralesional purified protein derivative (PPD) in treatment of multiple warts: A comparative clinical and immunological study","volume":"29","author":"Abou-Taleb","year":"2019","journal-title":"Dermatol Ther"},{"key":"R27-14-20240828","doi-asserted-by":"crossref","first-page":"e12882","DOI":"10.1111\/dth.12882","article-title":"Effectiveness of intralesional vitamin D3 injection in the treatment of common warts: Single-blinded placebo-controlled study","volume":"32","author":"Kareem","year":"2019","journal-title":"Dermatol Ther"},{"key":"R28-14-20240828","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/dth.12230","article-title":"Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: A comparative clinical and immunological study","volume":"28","author":"Shaheen","year":"2015","journal-title":"Dermatol Ther"},{"key":"R29-14-20240828","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"R30-14-20240828","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/ijdvl.IJDVL_1028_15","article-title":"Clinicoepidemiologic study of verruca plana at a tertiary care center","volume":"84","author":"Masatkar","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R31-14-20240828","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1710-1492-4-4-139","article-title":"Peanut allergy: An overview","volume":"4","author":"Al-Ahmed","year":"2008","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R32-14-20240828","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaad.2009.07.023","article-title":"Intralesional immunotherapy of plantar warts: Report of a new antigen combination","volume":"63","author":"Gamil","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R33-14-20240828","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/ijd.12480","article-title":"Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: A promising approach","volume":"54","author":"Nofal","year":"2015","journal-title":"Int J Dermatol"},{"key":"R34-14-20240828","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.18203\/2320-6012.ijrms20161223","article-title":"A prospective randomized open label comparative study of efficacy and safety of intralesional measles, mumps, rubella vaccine versus 100% trichloroacetic acid application in the treatment of common warts","volume":"4","author":"Saini","year":"2016","journal-title":"Int J Res Med Sci"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.IDOJ_573_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:11:07Z","timestamp":1787771467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.IDOJ_573_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_573_20","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}